![David P. Hesson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David P. Hesson
Director/Board Member at GPC Biotech, Inc.
Profile
David P.
Hesson is currently a Director at GPC Biotech, Inc. He previously worked as a Member at Harvard University, Principal at DuPont Pharmaceuticals Co. and Neuron Corp., Vice President-Product Development at Promedior, Inc., and Principal at Message Pharmaceuticals, Inc. Hesson holds a doctorate degree from Massachusetts Institute of Technology.
David P. Hesson active positions
Companies | Position | Start |
---|---|---|
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Director/Board Member | - |
Former positions of David P. Hesson
Companies | Position | End |
---|---|---|
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | - |
Neuron Corp.
![]() Neuron Corp. Industrial MachineryProducer Manufacturing Part of Ai Holdings Corp., Neuron Corp. is a Japanese company that provides services to enable pilotless flights, from drone deliveries and search and rescue, to air taxis and cargo deliveries. The private company is based in Yokohama, Japan. Neuron, formerly espace networks, is a connectivity management platform for things that move, such as ships, planes and trains. Neuron was acquired by Ai Holdings Corp. from TB Group, Inc. on July 01, 2008 for $1.98 million. | Corporate Officer/Principal | - |
Message Pharmaceuticals, Inc.
![]() Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Corporate Officer/Principal | - |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Training of David P. Hesson
Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Neuron Corp.
![]() Neuron Corp. Industrial MachineryProducer Manufacturing Part of Ai Holdings Corp., Neuron Corp. is a Japanese company that provides services to enable pilotless flights, from drone deliveries and search and rescue, to air taxis and cargo deliveries. The private company is based in Yokohama, Japan. Neuron, formerly espace networks, is a connectivity management platform for things that move, such as ships, planes and trains. Neuron was acquired by Ai Holdings Corp. from TB Group, Inc. on July 01, 2008 for $1.98 million. | Producer Manufacturing |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
Message Pharmaceuticals, Inc.
![]() Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Message Pharmaceuticals, Inc. develops pharmaceutical drugs. It operates as research development company involved in RNA research and exploring other types of RNAs to look for RNA-binding proteins, especially to combat RNA viruses and to treat all major disease categories. Message Pharmaceuticals was founded in 2002 and is located in Malvern, PA | Health Technology |
- Stock Market
- Insiders
- David P. Hesson